These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 5773321)
21. Genetic characterization and protective immunity of cold-adapted attenuated avian H9N2 influenza vaccine. Lee JS; Kim HS; Seo SH Vaccine; 2008 Dec; 26(51):6569-76. PubMed ID: 18838096 [TBL] [Abstract][Full Text] [Related]
22. The relationship between hemagglutination and adsorption of influenza viruses on red blood cells of different animal species and their total sialic acid content. Lobodzińska M; Krizanová O Arch Immunol Ther Exp (Warsz); 1965; 13(6):631-8. PubMed ID: 5865327 [No Abstract] [Full Text] [Related]
23. Characterization of live influenza vaccine donor strain derived from cold-adaptation of X-31 virus. Lee KH; Seo SU; Song JM; Lee CM; Kim HA; Seong BL Vaccine; 2006 Mar; 24(11):1966-74. PubMed ID: 16343703 [TBL] [Abstract][Full Text] [Related]
24. [Effect of thermostabile inhibitors contained in the serum of the normal guinea pig on influenza virus A2 in tissue cultures]. Jandásek L Scr Med (Brno); 1965; 38(6):323-7. PubMed ID: 5849738 [No Abstract] [Full Text] [Related]
25. Chemoenzymatic synthesis and application of a sialoglycopolymer with a chitosan backbone as a potent inhibitor of human influenza virus hemagglutination. Makimura Y; Watanabe S; Suzuki T; Suzuki Y; Ishida H; Kiso M; Katayama T; Kumagai H; Yamamoto K Carbohydr Res; 2006 Aug; 341(11):1803-8. PubMed ID: 16716273 [TBL] [Abstract][Full Text] [Related]
26. Detection of human antibody to influenza C virus by hemagglutination inhibition and single radial haemolysis tests. Creţescu L; Zilişteanu E; Ioniţă E; Maţepiuc M; Niculescu IT Arch Roum Pathol Exp Microbiol; 1983; 42(4):313-6. PubMed ID: 6380450 [No Abstract] [Full Text] [Related]
27. Effect of immobilization, cold and cold-restraint stress on liver monooxygenase activity and lipid peroxidation of influenza virus-infected mice. Mileva M; Bakalova R; Tancheva L; Galabov S Arch Toxicol; 2002 Mar; 76(2):96-103. PubMed ID: 11914779 [TBL] [Abstract][Full Text] [Related]
28. Two doses of parenterally administered split influenza virus vaccine elicited high serum IgG concentrations which effectively limited viral shedding upon challenge in mice. Hovden AO; Cox RJ; Madhun A; Haaheim LR Scand J Immunol; 2005 Oct; 62(4):342-52. PubMed ID: 16253121 [TBL] [Abstract][Full Text] [Related]
29. A chromatographic procedure for the purification of influenza virus. Pepper DS J Gen Virol; 1967 Jan; 1(1):49-55. PubMed ID: 6060242 [No Abstract] [Full Text] [Related]
30. Hemolysis and fusion by influenza viruses with heat-inactivated neuraminidase activity. Hosaka Y; Seriburi O; Moran MG; Yasuda Y; Fukai K; Nerome K Biken J; 1982 Jun; 25(2):51-62. PubMed ID: 7138491 [TBL] [Abstract][Full Text] [Related]
31. Characterization of antigenic structure of influenza A2 virus strains isolated in the 1965 epidemic. Ritova VV; Schastny EI; Oganesyan OT; Larionov AC J Hyg Epidemiol Microbiol Immunol; 1967; 11(1):18-26. PubMed ID: 6070330 [No Abstract] [Full Text] [Related]
32. Communications. Antigenic relationship between the equine and the Hong Kong human variant of influenza type A2 virus. Kasel JA; Fulk RV; Couch RB J Immunol; 1969 Feb; 102(2):530-2. PubMed ID: 5812724 [No Abstract] [Full Text] [Related]
33. The absence of inhibitor-destroying activity in neurotropic influenza A viruses. Hobson D; Gould EA; Flockton HI J Gen Microbiol; 1968 Mar; 50(3):Suppl:v-vi. PubMed ID: 5652085 [No Abstract] [Full Text] [Related]
34. [Antigenic drift of a strain of influenza equi virus isolated in France during the winter of 1978-1979]. Plateau E; Crucière C; Gayot G Ann Rech Vet; 1983; 14(1):71-7. PubMed ID: 6614786 [TBL] [Abstract][Full Text] [Related]
35. The effect of bacterial peptidoglycans on the immune response of hamsters to influenza virus vaccines. Crawford CR; Jennings R; Bradford N; Potter CW Clin Exp Immunol; 1982 Jun; 48(3):739-46. PubMed ID: 6811173 [TBL] [Abstract][Full Text] [Related]
36. Development and characterization of a live attenuated influenza B virus vaccine candidate. Seo SU; Byun YH; Lee EY; Jung EJ; Jang YH; Kim HA; Ha SH; Lee KH; Seong BL Vaccine; 2008 Feb; 26(7):874-81. PubMed ID: 18207290 [TBL] [Abstract][Full Text] [Related]
37. [Viral characteristics and immunologic reactions of the body during adaptation of influenza virus type A to mice. III. Biological properties of viruses used for adaptation and mouse-adapted viruses]. Loza-Tulimowska M Med Dosw Mikrobiol; 1984; 36(1):55-61. PubMed ID: 6330475 [No Abstract] [Full Text] [Related]
38. [Antibodies against influenza--individual and group immunity (author's transl)]. Farník J; Bruj J; Skocil V Cesk Epidemiol Mikrobiol Imunol; 1980 Jan; 29(1):33-8. PubMed ID: 6445784 [No Abstract] [Full Text] [Related]
39. Influenza virus-like particles produced by transient expression in Nicotiana benthamiana induce a protective immune response against a lethal viral challenge in mice. D'Aoust MA; Lavoie PO; Couture MM; Trépanier S; Guay JM; Dargis M; Mongrand S; Landry N; Ward BJ; Vézina LP Plant Biotechnol J; 2008 Dec; 6(9):930-40. PubMed ID: 19076615 [TBL] [Abstract][Full Text] [Related]
40. Sensitization of erythrocytes by influenza virus antigen. Gorbunova AS; Sokovykh LI J Immunol; 1967 Nov; 99(5):1048-54. PubMed ID: 6065106 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]